We studied the effect of lipids on the activity of a neutral cysteine proteinase, calpain, in subcellular fractions obtained from the rat brain. Extraction of nearly 23% of membrane cholesterol from the coarse mitochondrial fraction did not result in modifications of specific activity of calpain in this fraction. Detergents (digitonin or Triton Х-100) used in 0.3% concentration enhanced the activity of calpain in the coarse mitochondrial fraction. Examination of the effects of preparations of different phospholipids on the activity of calpain in the cytoplasm demonstrated that only phosphatidylcholine, but not phosphatidylserine and/or cardiolipin, insignificantly increased the activity of calpain (independently of the size and structure of phospholipid vesicles). We hypothesize that the mechanisms underlying interaction between calpain and lipids are not universal; in native cells and model experiments, they can differ noticeably from each other and are modified depending on the corresponding conditions.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
G. Lynch and M. Baudry, “The biochemistry of memory: a new and specific hypothesis,” Science, 224, No. 4653, 1057–1063 (1984).
T. F. Kastrykina and M. K. Malysheva, “Calpain as one of the calcium signal mediators in the cell,” Neurophysiology, 32, No. 2, 111–124 (2000).
L. Casaletti, S. Tauhata, J. Moreira, and R. Larson, “Myosin-Va proteolysis by Ca2+/calpain in depolarized nerve endings from rat brain,” Biochem. Biophys. Res. Commun., 308, No. 1, 159–164 (2003).
D. Goll, V. Thompson, H. Li, et al., “The calpain system,” Physiol. Rev., 83, No. 3, 731–801 (2003).
K. Takeuchi, K. Saito, and R. Nixon, “Immunoassay and activity of calcium-activated neutral proteinase (mCANP): distribution in soluble and membrane-associated fractions in human and mouse brain,” J. Neurochem., 58, No. 4, 1526–1532 (1992).
N. Banik, A. Chakrabarti, and E. Hogan, “Effects of detergents on Ca-activated neural proteinase (calpain) in neural and non-neural tissue: a comparative study,” Neurochem. Res., 17, No. 8, 797–802 (1992).
F. Zalewska, B. Zablocka, T. Saido, et al., “Dual response of calpain to rat brain postdecapitative ischemia,” Mol. Chem. Neuropathol., 33, No. 3, 185–197 (1998).
G. Broutman and M. Baudry, “Involvement of the secretory pathway for AMPA receptors in NMDA-induced potentiation in hippocampus,” J. Neurosci., 21, No. 1, 27–34 (2001).
U. Zimmerman, S. Malek, L. Liu, and H. Li, “Proteolysis of synaptobrevin, syntaxin, and SNAP-25 in alveolar epithelial type II cells,” IUBMB Life, 48, No. 4, 453–458 (1999).
K. Blomgren, A. McRae, A. Elmerd, et al., “The calpain proteolytic system in neonatal hypoxic ischemia,” Ann. N.Y. Acad. Sci., 825, 104–119 (1997).
G. DiRosa, T. Odrijin, R. Nixon, and O. Arancio, “Calpain inhibitors: a treatment for Alzheimer’s disease,” J. Mol. Neurosci., 19, Nos. 1/2, 135–141 (2002).
H. Wu, K. Tomizawa, Y. Oda, et al., “Critical role of calpain-mediated cleavage of calcineurin in excitotoxic neurodegeneration,” J. Biol. Chem., 279, No. 6, 4929–4940 (2004).
K. Wang, S. Lamer, G. Robinson, and R. Hayes, “Neuroprotection targets after traumatic brain injury,” Curr. Opin. Neurol., 19, No. 6, 514–519 (2006).
R. Sinjoanu, S. Kleinschmidt, R. Bitner, et al., “The novel calpain inhibitor A-705253 potently inhibits oligomeric beta-amyloid-induced dynamin 1 and tau cleavage in hippocampal neurons,” Neurochem. Int., 53, Nos. 3/4, 79–88 (2008).
M. Molinari and E. Carafoli, “Calpain: a cytosolic proteinase active at the membranes,” J. Membr. Biol., 156, No. 1, 1–8 (1997).
T. Yoschizawa, H. Sorimachi, S. Tomioka, et al., “Calpain dissociates into subunits in the presence of calcium ions,” Biochem. Biophys. Res. Commun., 208, No. 1, 376–383 (1995).
H. Kawasaki and S. Kawashima, “Regulation of the calpain-calpastatin system by membranes,” Mol. Membr. Biol., 13, No. 4, 217–224 (1996).
L. I. Kolchinskay and M. K. Malysheva, “Activity of calpain in subcellular fractions of the rat brain,” Neurophysiology, 36, No. 4, 231–237 (2004).
C. Garret, P. Cottin, J. Dufourcq, and A. Ducastaing, “Evidence for a Ca2+-independent association between calpain II and phospholipids vesicles,” FEBS Lett., 227, No. 2, 209–214 (1988).
A. Fernandez-Montalvan, I. Assflag-Machleidt, D. Pfeiler, et al., “mu-Calpain binds to lipid bilayers via the exposed hydrophobic surface of its Ca2+-activated conformation,” J. Biol. Chem., 387, No. 5, 617–627 (2006).
S. Pontremoli, E. Melloni, B. Sparatore, et al., “Role of phospholipids in the activation of the Ca2+-dependent neutral proteinase of human erythrocytes,” Biochem. Biophys. Res. Commun., 129, No. 2, 389–395 (1985).
S. Coolican and D. Hathaway, “Effect of L-alpha-phosphatidylinositol on a vascular smooth muscle Ca2+-dependent protease. Reduction of the Ca2+ requirement for autolysis,” J. Biol. Chem., 259, No. 19, 11627–11630 (1984).
T. Saido, M. Shibata, T. Takenawa, et al., “Positive regulation of mu-calpain action by polyphosphoinositides,” J. Biol. Chem., 267, No. 34, 24585–24590 (1992).
A. Chakrabarti, S. Dasgupta, R. Gadshen, et al., “Regulation of brain m-calpain Ca2+ sensitivity by mixtures of membrane lipids: activation by intracellular Ca2+ level,” J. Neurosci. Res., 44, No. 4, 374–380 (1996).
C. Sprague, T. Traley, H. Jang et al., “Phosphoinositide binding to the substrate regulates susceptibility to proteolysis by calpain,” J. Biol. Chem., 283, No. 14, 9217–9223 (2008).
D. Brown and E. London, “Structure and function of sphingolipid- and cholesterol-rich membrane rafts,” J. Biol. Chem., 275, No. 23, 17221–17224 (2000).
L. Morford, K. Forrest, B. Logan, et al., “Calpain II colocalizes with detergent-insoluble rafts on human and Jurkat T-cells,” Biochem. Biophys. Res. Commun., 295, No. 2, 540–546 (2002).
S. Goudeneqe, E. Darqelos, S. Claverol, et al., “Comparative proteomic analysis of myotube caveolae after milli-calpain deregulation,” Proteomics, 7, No. 18, 3289–3298 (2007).
P. Nuzzi, M. Senetar, and A. Huttenlocher, “Asymmetric localization of calpain 2 during neutrophil chemotaxis,” Mol. Biol. Cell, 18, No. 3, 795–805 (2007).
E. Babiychuk, K. Monastyrskaya, F. Burkhard, et al., “Modulating signaling events in smooth muscle: cleavage of annexin 2 abolishes its binding to lipid rafts,” FASEB J., 16, No. 10, 1177–1184 (2002).
O. Lowry, N. Rosenberg, A. Farr, et al., “Protein measurement with the Folin phenol reagent,” J. Biol. Chem., 193, No. 1, 265–275 (1951).
H. Maeda, “Assay of proteolytic enzymes by the fluorescence polarization technique,” Anal. Biochem., 92, No. 1, 222–227 (1979).
A. Zlatkis, B. Zak, and A. Boyle, “A new method for the direct determination of serum cholesterol,” J. Lab. Clin. Med., 41, No. 3, 486–492 (1953).
P. Yancey, W. Rodrigueza, E. Kilsdonk, et al., “Cellular cholesterol effluxmediatedbycyclodextrins.Demonstrationof kinetic pools and mechanism of efflux,” J. Biol. Chem., 271, No. 27, 16026–16034 (1996).
J. Hood, B. Logan, P. Sinai, et al., “Association of the calpain/calpastatin network with subcellular organelles,” Biochem. Biophys. Res. Commun., 310, No. 4, 1200–1212 (2003).
K. Haim, I. Ben-Aharon, and R. Shalgi, “Expression and immunolocalization of the calpain-calpastatin system during parthenogenetic activation and fertilization in the rat egg,” Reproduction, 131, No. 1, 35–43 (2006).
A. Kishimoto, N. Kajikawa, M. Shiota, and Y. Nishizuka, “Proteolytic activation of calcium-activated, phospholipids-dependent protein kinase by calcium-dependent neutral protease,” J. Biol. Chem., 258, No. 2, 1156–1164 (1983).
Author information
Authors and Affiliations
Corresponding author
Additional information
Neirofiziologiya/Neurophysiology, Vol. 41, No. 1, pp. 3–9, January–February, 2009.
Rights and permissions
About this article
Cite this article
Kolchinskaya, L.I., Тrikash, I.O., Gumenyuk, V.P. et al. Effect of Lipids on the Activity of Calpain in Subcellular Fractions Obtained from the Rat Brain. Neurophysiology 41, 1–7 (2009). https://doi.org/10.1007/s11062-009-9077-0
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11062-009-9077-0